Enza Lacivita

Also affiliated with University of Bari Aldo Moro

NeuroscienceBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 4 papers. Top paper: “Novel agonists for serotonin 5-HT7 receptors reverse metabotropic glutamate receptor-mediated long-term depression in the hippocampus of wild-type and Fmr1 KO mice, a model of Fragile X Syndrome”.

Novel agonists for serotonin 5-HT7 receptors reverse metabotropic glutamate receptor-mediated long-term depression in the hippocampus of wild-type and Fmr1 KO mice, a model of Fragile X Syndrome

Frontiers in Behavioral Neuroscience(2015)10.3389/fnbeh.2015.00065

N/A

0.596DataRank · unranked

52 citations

Lara M. Sardone, Enza Lacivita, Marcello Leopoldo, Lucia Ciranna, Lara Costa

Privileged scaffold-based design to identify a novel drug-like 5-HT7 receptor-preferring agonist to target Fragile X syndrome

European Journal of Medicinal Chemistry(2020)10.1016/j.ejmech.2020.112395

N/A

0DataRank · unranked

14 citations

Mauro Niso, Madia Letizia Stama, Anna L. Arzuaga, Concetta Altamura, Lara Costa +5 more

Design, Synthesis, Biological Evaluation, and Computational Studies of Novel Ureidopropanamides as Formyl Peptide Receptor 2 (FPR2) Agonists to Target the Resolution of Inflammation in Central Nervous System Disorders

Journal of Medicinal Chemistry(2022)10.1021/acs.jmedchem.1c02203

N/A

0DataRank · unranked

14 citations

Maria Favia, Igor A. Schepetkin, Lylia N. Kirpotina, Ewa Trojan, Mauro Niso +11 more

Development of potent isoflavone-based formyl peptide receptor 1 (FPR1) antagonists and their effects in gastric cancer cell models

European Journal of Medicinal Chemistry(2023)10.1016/j.ejmech.2023.115854

N/A

0DataRank · unranked

6 citations

Federica Sarcina, Igor A. Schepetkin, L.N. Kirpotina, Marialessandra Contino, Annalisa Schirizzi +7 more